Drug Profile
KN 015
Alternative Names: KN-015Latest Information Update: 28 Jul 2020
Price :
$50
*
At a glance
- Originator Alphamab
- Developer Jiangsu Alphamab Biopharmaceuticals
- Class Infertility therapies
- Mechanism of Action Follicle stimulating hormone modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Infertility
Most Recent Events
- 28 Jul 2020 No recent reports of development identified for phase-I development in Infertility(In volunteers) in China (SC, Injection)
- 01 Jun 2017 Phase-I clinical trials in Infertility (In volunteers) in China (SC) (NCT03192527)
- 01 Jun 2017 Preclinical trials in Infertility in China (SC)